As use of suxamethonium is associated with a large number of undesirable and serious side effects, including cardiac arrhythmias and malignant hyperthermia. These undesirable effects have prompted anesthesiologists to restrict use of suxamethonium. The low dose of the drug is expected to have lower side effects without compromising its neuromuscular blocking properties as the dose dependent side effects have been known for long, so the present study carried out to compare the efficacy of high dose (1.5mg/Kg) of suxamethonium to that of low dose (0.5mg/Kg) assessed by intubation condition with neuromuscular blockade. We prospectively randomized and compared the intubating conditions with neuromuscular monitoring in 100 patients undergoing elective abdominal, gynaecological and limb surgery in CMS-TH and found duration of apnoea and time taken for recovery of twitch height was significantly shorter. Without compromising the quality of neuromuscular blockade. Suxamethonium or Succinylcholine can be used in lower doses (0.5 mg/kg) in elective cases without airway compromise to achieve intubation.
Introduction
Succinylcholine also known as suxamethonium is a depolarizing type of neuromuscular blocking drug. Rapid onset and short duration of neuromuscular block produced by this drug is unique amongst the neuromuscular blocking drugs described so far. 1 There have been many efforts to reduce the period of onset of action of other neuromuscular blocking drugs by using large doses or by employing priming principle but no drug has been noticed to produce adequate intubating conditions in less than 90 seconds including newer drugs like mivacurium and rocuronium. 2, 3 It produces adequate intubating conditions within 30-40 seconds which lasts for 6- Table-2 shows distribution of cases in both groups as regards fall of twitch height to 10% of control. In group I it took place within 40-50 seconds in most (94%) of cases whereas in 90% of cases of group II, it was observed to be between 30-40 seconds.
All the patients in both the groups demonstrated a reduction in twitch height to 10% within 55 seconds. 
Discussion
Suxamethonium can be used in lower doses (0.5 mg/kg) in elective cases without airway compromise to achieve intubation. In the present study twitch height depression of 90% was taken to be the point at which intubation was attempted Overall intubating conditions were judged to be similar in both groups.
Though higher proportion of patients in group II had excellent condition. Therefore, it is pertinent to use low-dose of Suxamethonium for the intubation of patients during surgery. However, it is stressed that in cases where rapid sequence induction is required because of high risk of airways contamination, larger dose of suxamethonium should be used only to ensure optimal intubating condition in every case unless one is well conversant with low dose of suxamethonium.
Conclusion
Present study, supported by reports in literature demonstrates that twitch height depression to 10%
of control occurs delayed in low-dose group but duration of apnoea and time taken for recovery of twitch height is significantly shorter without compromising of neuromuscular blockade.
Suxamethonium or Succinylcholine can be used in lower doses (0.5 mg/kg) in elective cases without airway compromise to achieve intubation.
